IQ-AI Limited (GB:IQAI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
IQ-AI Limited has appointed Dr. Al Musella, a prominent figure in brain tumor research, as a Non-Executive Director. Dr. Musella’s extensive experience and influential network are expected to enhance IQ-AI’s ongoing projects in oral gallium maltolate development and its core imaging business. Meanwhile, Vinod Kaushal has resigned from his position as a non-executive director.
For further insights into GB:IQAI stock, check out TipRanks’ Stock Analysis page.